BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Prostate
,
Neocentromeres
,
Rapamycin
,
rs2476601
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PI-3 kinase
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thalamus lateral nuclei
Parotid gland
Substantia nigra pars compacta
Caudate
Ileum mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Binding and selectivity studies of phosphatidylinositol 3-kinase (PI3K) inhibitors.
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven…
PI3K block restores age-dependent neurovascular coupling defects associated with cerebral small vess…
Targeting the PI3K pathway in myeloproliferative neoplasms.
PI3K Isoform-Specific Regulation of Leader and Follower Cell Function for Collective Migration and P…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Gen…
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
Adaptive COVID-19 Treatment Trial 3 (ACTT-3)
Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Mu…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ